We have a proud history of providing pharmacovigilance consultancy to clients to help them overcome challenges and optimise their safety processes. Whether you need support in design of a PV system, changing or upgrading your safety database or implementation of new technologies to enhance your safety processes, activities post company merger or acquisition of a new product, or managing a safety issue, the DSSL team of dedicated and experienced consultants are here to provide guidance and support.READ MORE
At DSSL, we offer flexible sourcing solutions to support your pharmacovigilance system, or in many cases our clients ask us to provide a full PV service, including the provision of the EU QPPV or signal management in pharmacovigilance. Onto every project we deploy an experienced team of professionals who bring with them a bespoke approach to ensure you get the highest quality, value added service. Our services include:
We Take Care of All Your Pharmacovigilance Needs!
We, at Drug Safety Solutions, are thoroughly aware of the fact that biopharmaceutical and pharmaceutical companies need to ensure that their Pharmacovigilance (PV) and Medical Information (MI) needs are being managed efficiently and correctly. This is the reason why a significant share of our regulatory services are focused on efficient Pharmacovigilance Case Processing and Reporting Services.
Our Qualified Person Responsible for Pharmacovigilance (QPPV) excel in offering a competitive and accurate Adverse Event Reporting (ADR) system. By affiliating with the professionals at Drug Safety Solutions, our clients get entitled to an extensive range of services for their product life cycle.
Risk Management Plan RMP is described as a risk management system that contains data concerning the risks identified, possible risks, and missing information about a drug. It significantly outlines any measures to mitigate risks involved and provides information regarding effective monitoring of these measures. Moreover, for every new applicationof products within the European Union (EU), Risk Management Plan (RMP) is required to be submitted to the European Medicines Agency (EMA).READ MORE
DSSL’s knowledge is deep and varied, and the service is attentive and intuitive – they have a CAN-DO attitude.
Their collaborative approach is bespoke and client-centric. At every stage we were clear on who is doing what, when and how. The results speak for themselves.